Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.

× No keyword cloud information.

30 in total

Review 1. Does rituximab increase the incidence of infectious complications? A narrative review.

Authors: Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal: Int J Infect Dis Date: 2010-11-11 Impact factor: 3.623

2. Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient.

Authors: Ugur Unluturk; Sercan Aksoy; Ozlem Yonem; Yusuf Bayraktar; Gulten Tekuzman
Journal: World J Gastroenterol Date: 2006-03-28 Impact factor: 5.742

Review 3. Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.

Authors: Donald R Shaffer; Cliona M Rooney; Stephen Gottschalk
Journal: Immunotherapy Date: 2010-09 Impact factor: 4.196

4. Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder.

Authors: Makoto Hirokawa; Yoshinari Kawabata; Naohito Fujishima; Tomoko Yoshioka; Ken-ichi Sawada
Journal: Int J Hematol Date: 2007-10 Impact factor: 2.490

5. Infectious complications of immune modulatory agents.

Authors: Ricardo M La Hoz; John W Baddley
Journal: Curr Infect Dis Rep Date: 2013-12 Impact factor: 3.725

Review 6. How I treat EBV lymphoproliferation.

Authors: Helen E Heslop
Journal: Blood Date: 2009-09-01 Impact factor: 22.113

7. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.

Authors: Jing Lu Kroll; Craig Beam; Shaobing Li; Raphael Viscidi; Bonnie Dighero; Alice Cho; David Boulware; Mark Pescovitz; Adriana Weinberg
Journal: J Clin Virol Date: 2013-02-17 Impact factor: 3.168

8. Cytomegalovirus infection in pediatric rheumatic diseases: a review.

Authors: Eli M Eisenstein; Dana G Wolf
Journal: Pediatr Rheumatol Online J Date: 2010-05-20 Impact factor: 3.054

9. Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.

Authors: Yin-Hua Wang; Lei Fan; Li Wang; Run Zhang; Ji Xu; Cheng Fang; Jian-Yong Li; Wei Xu
Journal: Support Care Cancer Date: 2012-11-15 Impact factor: 3.603

10. Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia.

Authors: Wouter Meersseman; Katrien Lagrou; Raf Sciot; Johan de Jonckheere; Christine Haberler; Julia Walochnik; Willy E Peetermans; Eric van Wijngaerden
Journal: Emerg Infect Dis Date: 2007-03 Impact factor: 6.883